United States AI in Clinical Trials Market to Grow at 14.55% CAGR, Reaching USD 5.06 Billion by 2033, Led by IQVIA, Medidata, and IBM Watson Health | DataM Intelligence

The global AI in Clinical Trials Market reached USD 1.45 billion in 2024, and is projected to reach USD 5.06 billion by 2033, growing at a CAGR of 14.55% during the forecast period 2025-2033, according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2025, IQVIA launched an AI-powered platform that reduced patient recruitment time by 40% in Phase III oncology trials.
✅ In October 2025, the FDA approved the first AI-driven clinical trial design platform for adaptive trial protocols.
✅ In October 2025, Medidata Solutions introduced an AI-based monitoring system, cutting trial monitoring costs by 35%.

Japan: Recent Industry Developments

✅ In October 2025, Astellas Pharma implemented AI-powered prediction systems, improving trial success rates by 25%.
✅ In October 2025, Japan's PMDA established a regulatory framework for AI-based clinical trial endpoints.
✅ In October 2025, Sony AI Research partnered to develop generative AI models for synthetic control arms.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/ai-in-clinical-trials-market?jd

Market Trends & Drivers

The AI in Clinical Trials Market is experiencing rapid growth driven by the need to reduce drug development costs, accelerate trial timelines, and improve success rates. Key trends include predictive analytics for patient recruitment, AI-powered risk-based monitoring, and generative AI for synthetic control arms. The increasing complexity of clinical trials, rising R&D costs, and regulatory support for digital innovation are significantly accelerating market adoption.

Competitive Landscape

The market features intense competition among CROs, technology providers, and pharmaceutical companies.

IQVIA Holdings Inc. leads in AI-powered clinical trial solutions with integrated data analytics.
Medidata Solutions dominates in AI-driven clinical trial management and monitoring platforms.
IBM Watson Health provides AI solutions for clinical trial optimization and evidence generation.
NVIDIA Corporation offers AI computing platforms for medical imaging analysis.
Saama Technologies, Inc. specializes in AI-powered clinical data analytics and automation.
Unlearn.AI, Inc. pioneers digital twin technology for clinical trials.
Aetion, Inc. focuses on AI-driven real-world evidence generation.
BioSymetrics Inc. provides machine learning for biomarker discovery.
Concerto HealthAI offers AI solutions for oncology clinical trials.
Trials.AI develops AI-powered platforms for protocol optimization.

Segmentation

By Offering: Software, Services
By Trial Phase: Phase I, Phase II, Phase III
By Indication: Oncology, Central Nervous System (CNS) Disorders, Cardiovascular (CVS) Diseases, Other Indications
By End-User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Other End Users

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/ai-in-clinical-trials-market?jd

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (Germany, U.K., France, Italy, Spain, Rest of Europe)
⇥ Asia-Pacific (Japan, China, India, South Korea, Australia, Rest of Asia Pacific)
⇥ South America (Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.

This release was published on openPR.